This is a large scale study involving fluoxetine (Prozac) versus a placebo in the treatment
of adolescents with alcohol use disorder (AUD) and major depression (MDD). All individuals
will receive treatment for 12 weeks with a followup phase lasting 9 months.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)